
Marc Kealey
Chairman of the Board, Director
- Over 30 years’ experience in business and advocacy.
- Active in prescription drug reform, smoke free legislation, cannabis regulation and cross border healthcare initiatives.
- Rich practical experience in governance, public policy and politics.
- A political advisor to former Prime Minister Rt. Hon. John N. Turner from 1984-1990.
- Was responsible for health policy and political strategy for Prime Minister Turner and was a key advisor and tactician in the federal elections of 1984 and 1988.

Jie Luo
Vice Chairman of the Board, Director
- Specializes in international resource integration, investment and financing planning, and capital management.
- Extensive hands-on experience in U.S. public listings and international mergers and acquisitions.
- Capital advisor for multiple U.S. publicly listed companies. Excelling in fund establishment, management, and high-level Wall Street connections.

Simon Tang
Director, Doctorate Degree
- Famous M&A and fund management expert.
- Bachelor of Arts from the University of Utah.
- Master’s in Global Geopolitics from Brigham Young University.
- Ph.D. in Economics and History from the University of California, and a Juris Doctor from the University of Minnesota School of Law.

Charles Y. Fu
Senior Vice President, Director
- Mr. Charles Y. Fu is an attorney admitted to practice law in New York, Texas and China. He is also a frequent speaker at The Cambridge International Symposium on Economic Crime in Jesus College, Cambridge University, U.K., and a guest lecturer at Zhejiang University School of Law (Hongzhou, China) in international business transactions.
- With nearly 40 years of experience in corporate law, financial law, M&A, and securities law, Mr. Fu possesses extensive expertise in European and American legal practices and has substantial hands-on experience, particularly in international financing, where he has cultivated an extensive network of high-level resources. He has served as a long-term legal advisor for many renowned companies in Europe, the United States, and China.
- He has also led and been responsible for multiple Chinese companies going public on the main board in the United States, as well as U.S. and European companies listing on the main board in Hong Kong.
- Mr. Fu has extensive experience in corporate management, he was the Senior Vice President and General Counsel – Asia Pacific of the Texas-based conglomerate Paul Broadhead Interests, Inc., which was one of the top ten largest shopping mall developers in the U.S. and the cofounder and holding company of Cinemark, now the third largest movie theater chain in the U.S.
- He also founded and managed a visual effect company in China, taking many outsourcing visual effects works from Hollywood studios, prior to its sale to a group of Chinese investors in 2013. He was also the visual effect producer for a major Chinese box office movie On My Way in 2012.
- Mr. Fu is also an equity partner in Guang He Law Firm (formerly, Fu & Tong), one of the top ten largest law firms in China with more than 1,200 lawyers. Mr. Fu also founded and manages Guang He Law Firm’s New York Office – GH law Firm LLC.

Lawrence Chen
Director, Master Degree
- Graduated with an EMBA (Masters) from Nanyang Technological Institute, Singapore.
- Having extensive experience in multinational enterprise project development, operational management, and capital operations.
- Possessing outstanding leadership abilities, strong marketing planning and sales skills, and the experience and capability to rapidly improve corporate performance.
- Over 30 years of international entrepreneurial and managerial experience in the corporate sector, as well as abundant North American business resources and exceptional comprehensive abilities to enhance corporate operations and management.
- Won two China Luban Awards in 2005 and 2018 respectively.
Board Diversity Matrix
The table below provides certain information regarding the diversity of our board of directors as of November 22, 2022 and remains unchanged as of May 18, 2023:
